Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-22 Sale | 2022-02-24 4:28 pm | Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 11,228 | $2.4188 | $27,158 | 569,780 (Direct) | View |
| 2021-04-12 Sale | 2021-04-13 5:06 pm | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 10,000 | $4.0725 | $40,725 | 496,824 (Direct) | View |
| 2021-01-13 Sale | 2021-01-15 4:03 pm | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 10,000 | $6.0058 | $60,058 | 406,824 (Direct) | View |
| 2021-01-11 Sale | 2021-01-12 4:02 pm | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 10,000 | $5.7244 | $57,244 | 416,824 (Direct) | View |
| 2020-01-13 Sale | 2020-01-14 4:40 pm | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 10,000 | $5.4992 | $54,992 | 421,824 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-31 Option Award | 2023-02-01 4:12 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 150,000 | $0 | 719,780 (Direct) | View |
| 2022-02-22 Exercise | 2022-02-24 4:28 pm | 2022-02-22 2022-02-23 | Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 11,228 | $0 | 569,780 (Direct) | View |
| 2022-02-22 Exercise | 2022-02-24 4:28 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 11,228 | $0.69 | 569,780 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 6:15 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 75,000 | $0 | 569,780 (Direct) | View |
| 2021-10-05 Option Award | 2021-10-05 7:46 pm | N/A 2022-02-23 | Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 609,382 | $0 | 609,382 (Direct) | View |
| 2021-10-05 Disposition | 2021-10-05 5:34 pm | N/A 2022-02-23 | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 609,382 | $0 | 0 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:17 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 100,000 | $0 | 506,824 (Direct) | View |
| 2020-12-16 Gift | 2020-12-17 4:40 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 10,000 | $0 | 426,824 (Direct) | View |
| 2020-08-14 Option Award | 2020-08-17 4:26 pm | N/A 2030-08-14 | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 25,000 | $0 | 461,824 (Direct) | View |
| 2020-01-31 Option Award | 2020-03-02 4:57 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 15,000 | $0 | 436,824 (Direct) | View |
| 2019-11-19 Gift | 2019-11-20 4:44 pm | N/A N/A | XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer | 17,500 | $0 | 431,824 (Direct) | View |